| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | SB 239063 |
|---|
| Description | Potent and selective p38 MAP kinase inhibitor (IC50 = 44 nM for p38α). Displays > 220-fold selectivity over ERK, JNK1 and other kinases; ~ 3-fold more selective than SB 203580 (Cat. Nos. 1202 and 1402). Reduces inflammatory cytokine production and is neuroprotective following oral administration in vivo. Purity 98%. MW (observed): 368.41 |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | trans-4-[4-(4-Fluorophenyl)-5-(2-methoxy-4-pyrimidinyl)-1H-imidazol-1-yl]cyclohexanol |
|---|
| Gene, Accession, CAS # | CAS: 193551-21-2 |
|---|
| Catalog # | 1962/10 |
|---|
| Price | |
|---|
| Order / More Info | SB 239063 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 16251188, 20412391, 22136135, 24069252, 24307181, 24567337, 25995479 |
|---|
| 產(chǎn)品資料 |
|
|